(Q47586683)

4 February 2018

title

Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation. (English)

1 reference

4 February 2018

1 reference

1 reference

Rahbar S

1

1 reference

4 February 2018

Natarajan R

2

1 reference

4 February 2018

Yerneni K

3

1 reference

4 February 2018

Scott S

4

1 reference

4 February 2018

Gonzales N

5

1 reference

4 February 2018

Nadler JL

6

1 reference

4 February 2018

publication date

1 November 2000

1 reference

4 February 2018

published in

Clinica Chimica Acta

1 reference

4 February 2018

volume

301

1 reference

4 February 2018

page(s)

65-77

1 reference

4 February 2018

issue

1-2

1 reference

4 February 2018

Advanced glycosylation: chemistry, biology, and implications for diabetes and aging

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Inactivation and loss of antigenicity of esterase by sugars and a steroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Advanced glycosylation end products in patients with diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Mechanisms of maturation and ageing of collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Immunochemical evidence for increased formation of advanced glycation end products and inhibition by aminoguanidine in diabetic rat lenses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Lipid and lipoprotein modification by advanced glycosylation end-products: role in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Immunohistochemical and ELISA assays for biomarkers of oxidative stress in aging and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Glyoxalase System in Clinical Diabetes Mellitus and Correlation with Diabetic Complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Free radicals generated during the glycation reaction of amino acids by methylglyoxal. A model study of protein-cross-linked free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Isolation, purification, and characterization of amadoriase isoenzymes (fructosyl amine-oxygen oxidoreductase EC 1.5.3) from Aspergillus sp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Methylglyoxal-modified arginine residues — a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Effect of methylglyoxal on the physico-chemical and biological properties of low-density lipoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Hydroxyalkenal formation induced by advanced glycosylation of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Carboxymethylethanolamine, a biomarker of phospholipid modification during the maillard reaction in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

D-lysine reduces the non-enzymatic glycation of proteins in experimental diabetes mellitus in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Significance of fructose-induced protein oxidation and formation of advanced glycation end product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Role of fructose in glycation and cross-linking of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Novel inhibitors of advanced glycation endproducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

A new rapid method to detect inhibition of Amadori product generated by delta-gluconolactone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Protein cross-linking by the Maillard reaction. Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Advanced glycation end products: detection and reversal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

Advanced glycation end product-induced peroxisome proliferator-activated receptor gamma gene expression in the cultured mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900327-2

10.1016/S0009-8981(00)00327-2

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

11020463

1 reference

4 February 2018